AEGFX
Price
$61.68
Change
-$1.03 (-1.64%)
Updated
Jul 13 closing price
Net Assets
140.66B
AIECX
Price
$18.04
Change
-$0.30 (-1.64%)
Updated
Jul 13 closing price
Net Assets
1.88B
Interact to see
Advertisement

AEGFX vs AIECX

AEGFX vs AIECX Comparison Chart in %
View a ticker or compare two or three
VS
AEGFX vs. AIECX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Hold and AIECX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEGFX has more cash in the bank: 141B vs. AIECX (1.88B). AEGFX pays higher dividends than AIECX: AEGFX (2.53) vs AIECX (1.34). AEGFX was incepted earlier than AIECX: AEGFX (25 years) vs AIECX (29 years). AIECX (2.02) is less costly to investors than AEGFX (0.86). AEGFX (50.00) and AIECX (50.00) have comparable annual turnover. AEGFX has a lower initial minimum investment than AIECX: AEGFX (250) vs AIECX (1000). AEGFX annual gain was more profitable for investors over the last year : 5.43 vs. AIECX (-4.86). AEGFX return over 5 years is better than : -5.92 vs. AIECX (-37.36).
AEGFXAIECXAEGFX / AIECX
Total Expense Ratio0.862.0243%
Annual Report Gross Expense Ratio0.862.0243%
Fund Existence25 years29 years-
Gain YTD2.5279.16728%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets141B1.88B7,488%
Annual Yield % from dividends2.531.34189%
Returns for 1 year5.43-4.86-112%
Returns for 3 years16.61-0.09-18,128%
Returns for 5 years-5.92-37.3616%
Returns for 10 years45.30-31.63-143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LOTI26.23N/A
N/A
Liberty One Tactical Income ETF
INVG25.11-0.10
-0.39%
Gmo Systematic Investment Grade Credit ETF
BCHP37.04-0.28
-0.75%
Principal Focused Blue Chip ETF
BKIE99.40-1.01
-1.01%
BNY Mellon International Equity ETF
HELX39.73-0.45
-1.13%
Franklin Genomic Advancements ETF